Search

everythinglearnresearchcommunity

for

Search:↓

Patients with certain skin symptoms and high ANA titers should be monitored for potential systemic lupus.

Alopecia areata is likely caused by a combination of genetic factors and immune system dysfunction, and may represent different diseases with various causes.

Fat tissue cells are a promising option for healing various diseases, but more research is needed to ensure they are safe and effective.

Blocking IL-12/IL-23p40 helped reverse severe hair loss in patients.

Different types of hair loss in lupus need careful diagnosis for proper treatment.

Personalized treatment plans improve vitiligo care.

Intralesional triamcinolone acetonide is effective for treating patchy hair loss, and dermoscopy helps detect treatment response and side effects early.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Combination therapy with steroids and pimecrolimus improved or stabilized hair loss in most patients with Frontal Fibrosing Alopecia, who also had a high rate of hypothyroidism.

Bendamustine combined with rituximab is an effective and well-tolerated treatment for certain types of lymphoma.

Tailor treatments for vitiligo to patient needs for best results.

Lupus can cause hair loss and nail changes, with treatments available for both.

COVID-19 doesn't make alopecia areata worse.

Early treatment of fibrosing alopecia in a pattern distribution may improve outcomes.

Effective treatment for hidradenitis suppurativa varies, with antibiotics commonly used and surgery as an option, but no single method is universally successful.

Rubbing calcipotriol on the skin works better than taking vitamin D pills for treating mild to moderate alopecia areata.

Yellow dots and short vellus hairs are key signs for diagnosing alopecia areata using trichoscopy.

Collaborative care between physicians and pharmacists improved medication management for rheumatoid arthritis without raising costs.

People with alopecia areata had lower vitamin D levels, but these levels didn't relate to many aspects of the condition.

The document concludes that alopecia areata is an unpredictable autoimmune hair loss condition with no cure, but various treatments exist that require personalized approaches.

The conference presented findings on how vitamin D levels, genetic factors, and lifestyle choices like smoking and yoga affect various health conditions and diseases.

Trichoscopy is crucial for diagnosing and assessing alopecia areata in children.

Most patients with autoimmune blistering diseases experienced some hair loss, which may be underreported and linked to disease severity.

Hydroxychloroquine may help COVID-19 patients with lupus.

Patients with lupus nephritis and COVID-19 can improve with proper treatment.

NKG2D gene polymorphism doesn't affect SLE risk but may influence symptoms like rash and hair loss.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Hair transplants can cause hair loss if done while lichen planopilaris is active; wait until it's inactive for two years and check with a scalp biopsy first.

The document summarizes medical findings on topics like heart rhythm treatment, sleep apnea therapy, and various health conditions and treatments.

Lichen Planus is a less common condition affecting skin and mucous membranes, with various types and associated risk factors, challenging to diagnose, significantly impacts life quality, and may have a risk of cancerous changes in oral lesions.